4/A//SEC Filing
Sofia Michael J. 4/A
Accession 0001567619-18-001171
CIK 0001447028other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 3:14 PM ET
Size
6.1 KB
Accession
0001567619-18-001171
Insider Transaction Report
Form 4/AAmended
Sofia Michael J.
Chief Scientific Officer
Transactions
- Sale
Common Shares
2018-08-13$9.51/sh−4,250$40,436→ 167,162 total(indirect: By Trust)
Holdings
- 1,503,403
Common Shares
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.5073 to $9.5525, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001635324
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 3:14 PM ET
- Size
- 6.1 KB